Business Context and Reporting Period
This Form 8-K, dated May 1, 2026, reports the completion of a material transaction by Applied Digital Corporation (APLD) on May 5, 2026. The Company divested its cloud business (Applied Digital Cloud Corporation) to Ekso Bionics Holdings, Inc. in a business combination. Ekso Bionics changed its name to ChronoScale Corporation (trading symbol: CHRN). As a result of the transaction, APLD owns approximately 97% of ChronoScale's equity.
Key Financial Metrics and Transaction Details
- Transaction Structure: APLD contributed 100% of its cloud business equity to ChronoScale in exchange for 138,216,820 shares of ChronoScale common stock.
- Private Placement Financing: APLD purchased 1,311,407 shares of ChronoScale common stock at $12.01 per share, generating gross proceeds of approximately $15.75 million.
- Transaction Costs: A placement agent fee of approximately $0.75 million (5.0% of gross proceeds) was paid to Lake Street Capital Markets, LLC.
- Recurring Revenue Stream: APLD entered a Management Advisory and Corporate Services Agreement to receive fees equal to 1% of ChronoScale's gross revenue per quarter, plus monthly fees for corporate services.
- Financial Statements: This filing does not provide standalone revenue, profit, cash flow, or debt metrics for the reporting period; it focuses on the structural completion of the divestiture.
Material Changes Versus Prior Period
The primary material change is the structural separation of the cloud business from Applied Digital Corporation. The cloud business is now a wholly-owned subsidiary of ChronoScale Corporation. APLD retains a controlling interest (approx. 97%) in the new entity. The Company's capital structure has changed to include a significant equity stake in ChronoScale rather than direct ownership of the cloud assets.
Guidance, Outlook, and Governance Rights
Management Commentary and Outlook: The filing contains forward-looking statements regarding the integration of the cloud compute business with the legacy Ekso business and the development of High Power Compute (HPC) data centers. Management views ChronoScale as the "go forward accelerated compute platform."
Governance and Control: Under the Investor Rights Agreement, APLD retains significant control over ChronoScale:
- Board Designation: APLD has the right to designate 4 of the 7 directors on ChronoScale's Board, including the Chairman, as long as APLD investors own at least 50% of voting securities.
- Approval Rights: APLD must consent to major corporate actions (e.g., mergers, asset sales over $100 million, debt issuance, CEO/CFO changes) while holding at least 30% of voting securities.
- Preemptive Rights: APLD has rights to participate in future equity issuances to maintain its ownership percentage.
Risks: Key risks include the ability to integrate the businesses, secure financing for data center construction, maintain relationships with hyperscaler customers, and navigate regulatory changes in the AI and HPC sectors.
Investor Verification Checklist
- Verify the exact ownership percentage of ChronoScale held by APLD post-closing (stated as approx. 97%) and the dilution mechanics if APLD sells shares.
- Review the full text of the Management Advisory and Corporate Services Agreement to understand the specific scope of the 1% revenue fee and additional service fees.
- Confirm the status of the Form S-3 registration statement for the resale of APLD's ChronoScale shares, which is required within 60 days of closing.
- Assess the financial health and debt obligations of ChronoScale, as APLD's future value is now heavily tied to this subsidiary's performance.
- Monitor the integration progress of the cloud business with Ekso's legacy operations as described in the forward-looking statements.